WASHINGTON — Sen. Kamala Harris (D-Calif.) on Tuesday became the second leading Democratic primary candidate in as many days to unveil a comprehensive plan to lower drug prices.
Harris’s plan relies on government price-setting, allowing the federal government to cap price levels for drugs that are cheaper in other developed nations or whose prices increase by a rate exceeding inflation.
About the Author Reprints
Kill the goose that lays the golden eggs….who is going to innovate without the promise of profits? This is literally going to put the brakes on the current acceleration in the drug making space. Wonder why there is no innovation in antibiotics…no profit int it.